Literature DB >> 23648561

Pleiotropic antioxidant potential of rosuvastatin in preventing cardiovascular disorders.

Rajkiran Mahalwar1, Deepa Khanna.   

Abstract

Rosuvastatin is a promising synthetic hydrophillic statin which provides potential benefits in reducing cardiovascular risk factors. Rosuvastatin has potent ability to diminish low density lipoprotein, very low density lipoprotein, triglycerides and enhance high density lipoprotein level to manage high cholesterol level and associated cardiovascular diseases. Intriguingly, numerous studies demonstrated that rosuvastatin can reverse the cardiac disorders such as hypertension, atherosclerosis, ischemic heart disease, congestive heart failure and cardiomyopathy by reducing reactive oxygen species mediated oxidative stress. Rosuvastatin maintain the balance between oxidant generation and oxidant scavenging by reducing NADPH (nicotinamide adenine dinucleotide phosphate)-dependent production of reactive oxygen species, suppressing endothelial nitric oxide synthase (eNOS) uncoupling, inducing and upregulating antioxidant defense mechanism. This review, summaries pleiotropic antioxidant evidences of rosuvastatin in favor of cardioprotection.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23648561     DOI: 10.1016/j.ejphar.2013.04.025

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Hydrophilic Versus Lipophilic Statin Treatments in Patients With Renal Impairment After Acute Myocardial Infarction.

Authors:  Min Hye Kang; Weon Kim; Jin Sug Kim; Kyung Hwan Jeong; Myung Ho Jeong; Jin-Yong Hwang; Seung Ho Hur; Hyeon Seok Hwang
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

Review 2.  The effects of rosuvastatin on lipid-lowering, inflammatory, antioxidant and fibrinolytics blood biomarkers are influenced by Val16Ala superoxide dismutase manganese-dependent gene polymorphism.

Authors:  T Duarte; I B M da Cruz; F Barbisan; D Capelleto; R N Moresco; M M M F Duarte
Journal:  Pharmacogenomics J       Date:  2016-02-16       Impact factor: 3.550

3.  5,6-Benzoflavones as cholesterol esterase inhibitors: synthesis, biological evaluation and docking studies.

Authors:  Jatinder V Singh; Anumeet Kaur; Kavita Bhagat; Manish K Gupta; Manwinder Singh; Harbinder Singh; Preet Mohinder S Bedi
Journal:  Medchemcomm       Date:  2018-01-19       Impact factor: 3.597

4.  Effects of rosuvastatin on ADMA, rhokinase, NADPH oxidase, caveolin-1, hsp 90 and NFkB levels in a rat model of myocardial ischaemia-reperfusion.

Authors:  Oktay Burma; Elif Onat; Ayhan Uysal; Necip Ilhan; Deniz Erol; Mete Ozcan; Engin Sahna
Journal:  Cardiovasc J Afr       Date:  2014 Sep-Oct       Impact factor: 1.167

5.  Combined Antihypertensive Effect of Paeoniflorin Enriched Extract and Metoprolol in Spontaneously Hypertensive Rats.

Authors:  Bo Li; Zheng-Biao Yang; Shan-Sha Lei; Jie Su; Ze-Wu Jin; Su-Hong Chen; Gui-Yuan Lv
Journal:  Pharmacogn Mag       Date:  2018-02-20       Impact factor: 1.085

6.  The Antinociceptive Effects of Rosuvastatin in Chronic Constriction Injury Model of Male Rats.

Authors:  Amin Hasanvand; Fariba Ahmadizar; Abolfazl Abbaszadeh; Hossein Amini-Khoei; Mehdi Goudarzi; Amir Abbasnezhad; Razieh Choghakhori
Journal:  Basic Clin Neurosci       Date:  2018-07-01

Review 7.  Inflammation and Oxidative Stress in the Context of Extracorporeal Cardiac and Pulmonary Support.

Authors:  Sanaz Hatami; Joshua Hefler; Darren H Freed
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

8.  Rosuvastatin alleviates high-salt and cholesterol diet-induced cognitive impairment in rats via Nrf2-ARE pathway.

Authors:  Ibraheem Husain; Mohd Akhtar; Tushar Madaan; Malik Zainul Abdin; Mohammad Islamuddin; Abul Kalam Najmi
Journal:  Redox Rep       Date:  2018-12       Impact factor: 4.412

9.  Activated ROCK/Akt/eNOS and ET-1/ERK pathways in 5-fluorouracil-induced cardiotoxicity: modulation by simvastatin.

Authors:  Radwa Nasser Muhammad; Nada Sallam; Hanan Salah El-Abhar
Journal:  Sci Rep       Date:  2020-09-07       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.